Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination.

Lee JY, Kim MJ, Thomas S, Oorschot V, Ramm G, Aui PM, Sekine Y, Deliyanti D, Wilkinson-Berka J, Niego B, Harvey AR, Theotokis P, McLean C, Strittmatter SM, Petratos S.

J Neurosci. 2019 Jul 10;39(28):5562-5580. doi: 10.1523/JNEUROSCI.1760-18.2019. Epub 2019 May 6.

PMID:
31061088
2.

Intravitreal administration of endothelin type A receptor or endothelin type B receptor antagonists attenuates hypertensive and diabetic retinopathy in rats.

Alrashdi SF, Deliyanti D, Wilkinson-Berka JL.

Exp Eye Res. 2018 Nov;176:1-9. doi: 10.1016/j.exer.2018.06.025. Epub 2018 Jun 23.

PMID:
29944850
3.

Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy.

Deliyanti D, Alrashdi SF, Tan SM, Meyer C, Ward KW, de Haan JB, Wilkinson-Berka JL.

Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):815-825. doi: 10.1167/iovs.17-22920.

PMID:
29411009
4.

Effect of NADPH oxidase 1 and 4 blockade in activated human retinal endothelial cells.

Appukuttan B, Ma Y, Stempel A, Ashander LM, Deliyanti D, Wilkinson-Berka JL, Smith JR.

Clin Exp Ophthalmol. 2018 Aug;46(6):652-660. doi: 10.1111/ceo.13155. Epub 2018 Feb 23.

PMID:
29360265
5.

Endothelin-2 Injures the Blood-Retinal Barrier and Macroglial Müller Cells: Interactions with Angiotensin II, Aldosterone, and NADPH Oxidase.

Alrashdi SF, Deliyanti D, Talia DM, Wilkinson-Berka JL.

Am J Pathol. 2018 Mar;188(3):805-817. doi: 10.1016/j.ajpath.2017.11.009. Epub 2017 Dec 15.

PMID:
29248456
6.

Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination.

Lee JY, Kim MJ, Deliyanti D, Azari MF, Rossello F, Costin A, Ramm G, Stanley EG, Elefanty AG, Wilkinson-Berka JL, Petratos S.

EBioMedicine. 2017 Nov;25:122-135. doi: 10.1016/j.ebiom.2017.10.016. Epub 2017 Oct 19.

7.

Foxp3+ Tregs are recruited to the retina to repair pathological angiogenesis.

Deliyanti D, Talia DM, Zhu T, Maxwell MJ, Agrotis A, Jerome JR, Hargreaves EM, Gerondakis S, Hibbs ML, Mackay F, Wilkinson-Berka JL.

Nat Commun. 2017 Sep 29;8(1):748. doi: 10.1038/s41467-017-00751-w.

8.

The potential of anti-VEGF (Vasotide) by eye drops to treat proliferative retinopathies.

Wilkinson-Berka JL, Deliyanti D.

Ann Transl Med. 2016 Oct;4(Suppl 1):S41. No abstract available.

9.

Inhibition of the Nuclear Receptor RORγ and Interleukin-17A Suppresses Neovascular Retinopathy: Involvement of Immunocompetent Microglia.

Talia DM, Deliyanti D, Agrotis A, Wilkinson-Berka JL.

Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1186-96. doi: 10.1161/ATVBAHA.115.307080. Epub 2016 Apr 7.

PMID:
27055905
10.

A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy.

Deliyanti D, Lee JY, Petratos S, Meyer CJ, Ward KW, Wilkinson-Berka JL, de Haan JB.

Clin Sci (Lond). 2016 Aug 1;130(15):1375-87. doi: 10.1042/CS20160068. Epub 2016 Mar 22.

PMID:
27005782
11.

FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy.

Deliyanti D, Zhang Y, Khong F, Berka DR, Stapleton DI, Kelly DJ, Wilkinson-Berka JL.

PLoS One. 2015 Jul 29;10(7):e0134392. doi: 10.1371/journal.pone.0134392. eCollection 2015.

12.

Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina.

Deliyanti D, Wilkinson-Berka JL.

J Neuroinflammation. 2015 Jul 30;12:136. doi: 10.1186/s12974-015-0363-z.

13.

Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.

Figgett WA, Deliyanti D, Fairfax KA, Quah PS, Wilkinson-Berka JL, Mackay F.

J Autoimmun. 2015 Jul;61:9-16. doi: 10.1016/j.jaut.2015.04.007. Epub 2015 May 29.

PMID:
26027434
14.

Ebselen by modulating oxidative stress improves hypoxia-induced macroglial Müller cell and vascular injury in the retina.

Tan SM, Deliyanti D, Figgett WA, Talia DM, de Haan JB, Wilkinson-Berka JL.

Exp Eye Res. 2015 Jul;136:1-8. doi: 10.1016/j.exer.2015.04.015. Epub 2015 Apr 24.

PMID:
25912997
15.

Prorenin stimulates a pro-angiogenic and pro-inflammatory response in retinal endothelial cells and an M1 phenotype in retinal microglia.

Zhu T, Miller AG, Deliyanti D, Berka DR, Agrotis A, Campbell DJ, Wilkinson-Berka JL.

Clin Exp Pharmacol Physiol. 2015 May;42(5):537-48. doi: 10.1111/1440-1681.12376.

PMID:
25707593
16.

Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCα, and the renin-angiotensin-aldosterone system.

Deliyanti D, Armani R, Casely D, Figgett WA, Agrotis A, Wilkinson-Berka JL.

Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2033-41. doi: 10.1161/ATVBAHA.114.303792. Epub 2014 Jul 10.

PMID:
25012132
17.

NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.

Wilkinson-Berka JL, Deliyanti D, Rana I, Miller AG, Agrotis A, Armani R, Szyndralewiez C, Wingler K, Touyz RM, Cooper ME, Jandeleit-Dahm KA, Schmidt HH.

Antioxid Redox Signal. 2014 Jun 10;20(17):2726-40. doi: 10.1089/ars.2013.5357. Epub 2013 Oct 30.

18.

The TACI receptor regulates T-cell-independent marginal zone B cell responses through innate activation-induced cell death.

Figgett WA, Fairfax K, Vincent FB, Le Page MA, Katik I, Deliyanti D, Quah PS, Verma P, Grumont R, Gerondakis S, Hertzog P, O'Reilly LA, Strasser A, Mackay F.

Immunity. 2013 Sep 19;39(3):573-83. doi: 10.1016/j.immuni.2013.05.019. Epub 2013 Sep 5.

19.

Brain and retinal microglia in health and disease: an unrecognized target of the renin-angiotensin system.

McCarthy CA, Widdop RE, Deliyanti D, Wilkinson-Berka JL.

Clin Exp Pharmacol Physiol. 2013 Aug;40(8):571-9. doi: 10.1111/1440-1681.12099. Review.

PMID:
23601050
20.

The retinal renin-angiotensin system: roles of angiotensin II and aldosterone.

Wilkinson-Berka JL, Agrotis A, Deliyanti D.

Peptides. 2012 Jul;36(1):142-50. doi: 10.1016/j.peptides.2012.04.008. Epub 2012 Apr 17. Review.

PMID:
22537944
21.

Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy.

Deliyanti D, Miller AG, Tan G, Binger KJ, Samson AL, Wilkinson-Berka JL.

Hypertension. 2012 Mar;59(3):607-13. doi: 10.1161/HYPERTENSIONAHA.111.188136. Epub 2012 Jan 23.

PMID:
22275532
22.

Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat.

Wilkinson-Berka JL, Tan G, Binger KJ, Sutton L, McMaster K, Deliyanti D, Perera G, Campbell DJ, Miller AG.

Diabetologia. 2011 Oct;54(10):2724-35. doi: 10.1007/s00125-011-2239-9. Epub 2011 Jul 14.

PMID:
21755314

Supplemental Content

Loading ...
Support Center